跳至主要内容
临床试验/NCT00946933
NCT00946933已完成不适用

Effects of Chronic Acid-Base Changes on the Ventilatory and Perceptual Response to Hypercapnia, Hypoxia and Exercise in Healthy Older Adults

Queen's University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2009年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Breathlessness intensity (10-point Borg scale)

研究概览

简要总结

Approximately 30% of people aged 65 years and older experience breathlessness (perceived respiratory difficulty) during daily activity. The main causes of increased breathlessness in the healthy elderly are poorly understood and are the main focus of the proposed study. Some possible contributing factors include abnormalities in the control and/or mechanics of breathing. To evaluate these possible contributory factors, the investigators will compare ventilatory and perceptual responses to: 1) exercise, 2) increased levels of inspired carbon dioxide, and 3) reduced levels of inspired oxygen under strictly-controlled experimental conditions where the investigators increase or decrease breathing requirements by altering dietary salt intake in healthy 40-80 year old men and women.

Exercise and rebreathing tests will be performed at baseline and at the end of each 3 day treatment period. Breathlessness intensity will be measured and compared at a standardized work rate, ventilation or end-tidal PCO2 during these tests.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •healthy, regularly active adults
  • •non-smoking
  • •BMI 18-30 kg/m2

排除标准

  • •history of lung and/or heart disease (including cardiac arrhythmias) or other comorbidity which could interfere with proper conduct of the intervention or tests
  • •hypotension or hypertension
  • •hypercholesterolemia
  • •sleep disordered breathing
  • •inability to perform cycle exercise or comply with other testing procedures

研究组 & 干预措施

Placebo

Placebo Comparator

0.025 g/kg/day of NaCl (sodium chloride)

干预措施: placebo (Dietary Supplement)

High salt diet

Active Comparator

0.2 g/kg/day of NH4Cl (ammonium chloride)

干预措施: NH4Cl (ammonium chloride) (Dietary Supplement)

结局指标

主要结局

Breathlessness intensity (10-point Borg scale)

时间窗: Measured at the end of each 3 day treatment period

次要结局

  • Exercise capacity (peak VO2)(Measured at the end of each 3 day treatment period)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Denis O'Donnell

Principal Investigator

Queen's University

研究点 (1)

Loading locations...

相似试验